 |
SleepSleep disruption has a detrimental effect on quality of life and is a very important safety aspect in any clinical trial. Use of Cambridge Neurotechnology Clinical Services’ actigraphy based solutions allow the effects on sleep of the administration of a drug to be objectively monitored. |
 |
PLMSPeriodic Limb Movements in Sleep (PLMS) is an increasingly recognised symptom of Parkinson’s Disease and a number of other disorders of the central nervous system as well as being a serious condition in its own right. Using specialised software and Actiwatches mounted on the feet it is possible to measure the occurrence of PLMS in a patient. |
 |
TremorHistorically it has been necessary to rely on a patient or observer’s subjective assessment of the severity of Parkinsonian Tremor. Cambridge Neurotechnology Clinical Services is able to supply a solution for objectively quantifying the intensity and duration of tremor using the Tremorwatch, an accelerometer based unit which differentiates between tremor and other movement. A full range of in house analysis services are also available. |
 |
Daytime sedation & Post Drug Administration
Cambridge Neurotechnology Clinical Services is able to offer a service of extensive activity analysis, including studies of daytime rest and napping and pre/post event comparisons. It is possible to monitor the general changes in activity levels after a drug or therapy is administered or to look for specific activity patterns that are possible side effects of a treatment. |
